Publications in 2024

In 2024, I worked as the head of a group of bioinformaticians at BostonGene. Part of our department’s work involves scientific research on topical subjects that we either generate ourselves or receive as a client request. Participating in conferences allows us to present ourselves as experts in the field, make new acquaintances, and start projects.

As a project lead, I proposed research topics, kept track of deadlines and workloads. Below are selected projects.

American Society of Clinical Oncology

The main clinical oncology conference in the USA.

“Transcriptomic Analysis Identifies Novel Tumor Suppressor Gene Fusions in Bone Sarcomas”.
ASCO abstracts.

Society of Immunotherapy of Cancer

The largest conference on cancer immunotherapy; this year it took place in Barcelona.

“Identifying novel targets for antibody-drug conjugates in sarcomas using RNA sequencing”.
BostonGene news.
SITC abstracts.

Association of Molecular Pathology

A large conference in Canada attended by pathologists, pharma and biotech.

“Comparative Molecular Analysis of Clear Cell Sarcoma and Cutaneous Melanomas: Key Genetic Insights for diagnosis”. BostonGene news.
APM abstracts.

American Society of Hematology

The largest conference on lymphomas and blood disorders in the world.

“Gene Expression-Based Classifier Reclassifies Burkitt Lymphoma, HGBL NOS, DLBCL NOS, and Double/Triple Hit Lymphomas into Subtypes with More Mutational and Microenvironment Landscapes and Treatment Response”. BostonGene news.
ASH conference website.

San-Antonio Breast Cancer Symposium

The largest breast cancer conference in the world.

“Comprehensive Analysis of ADC Target Expression in Invasive Lobular Carcinoma”.
BostonGene news.

“Evaluating the Correlation Between FISH and NGS in Assessing ERBB2 Amplification in Breast Cancer: Insights and Implications”. BostonGene news.